Nucleoside phosphoramidate prodrugs
US8906880B2 · kind B2 · utility
48Cited by
122References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2014 |
| Grant date | Dec 9, 2014 |
| Priority date | — |
| Expiry date | Apr 17, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure:Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.